Salem Ivf Centre Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 2.62 Cr
as on 24-10-2024
- Company Age 10 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue -3.60%
(FY 2023)
- Profit 274.17%
(FY 2023)
- Ebitda 55.50%
(FY 2023)
- Net Worth 7.62%
(FY 2023)
- Total Assets 1.45%
(FY 2023)
About Salem Ivf Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.62 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kinettingal Kunjumoideen, Abhishek Aggrawal, and Shridhar Toshniwal serve as directors at the Company.
- CIN/LLPIN
U74999TZ2014PTC020878
- Company No.
020878
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Nov 2014
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Salem, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Salem Ivf Centre?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kinettingal Kunjumoideen  | Director | 17-Nov-2014 | Current |
| Abhishek Aggrawal | Director | 03-Jul-2024 | Current |
| Shridhar Toshniwal | Director | 03-Jul-2024 | Current |
Financial Performance and Corporate Structure Insights of Salem Ivf Centre.
Salem Ivf Centre Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.6% decrease. The company also saw a substantial improvement in profitability, with a 274.17% increase in profit. The company's net worth moved up by a moderate rise of 7.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Salem Ivf Centre?
In 2023, Salem Ivf Centre had a promoter holding of 100.00%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Asian Reproductive Centre Private LimitedActive 10 years 4 monthsKinettingal Kunjumoideen, Abhishek Aggrawal and 1 more are mutual person
Centre Of Human Reproduction And Biosciences Private LimitedActive 20 years 9 monthsAbhishek Aggrawal and Shridhar Toshniwal are mutual person
Babyscience Ivf Clinics Private LimitedActive 4 years 3 monthsAbhishek Aggrawal and Shridhar Toshniwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Salem Ivf Centre?
Salem Ivf Centre has a workforce of 12 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Salem Ivf Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Salem Ivf Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
